India's Piramal Pharma up after US FDA ends inspection at facility

Piramal Pharma (Mumbai)

15/07/2024 05:21

** Shares of Piramal Pharma  PIRM.NS  rise 2.3% to 154.53
rupees, set for best day in about a month
    ** Co says U.S. FDA completes inspection of Ahmedabad
facility with Zero Form - 483 observations - and 'no action
indicated' designation
    ** PIRM set to snap three-day losing streak
    ** Stock up ~11% YTD

 (Reporting by Dimpal Gulwani in Bengaluru)
 ((dimpal.gulwani@thomsonreuters.com))